ID   STAT1_MOUSE             Reviewed;         749 AA.
AC   P42225;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   18-JUN-2025, entry version 195.
DE   RecName: Full=Signal transducer and activator of transcription 1;
GN   Name=Stat1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymus;
RX   PubMed=7545930; DOI=10.1073/pnas.91.11.4806;
RA   Zhong Z., Wen Z., Darnell J.E. Jr.;
RT   "Stat3 and Stat4: members of the family of signal transducers and
RT   activators of transcription.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:4806-4810(1994).
RN   [2]
RP   PHOSPHORYLATION, FUNCTION, AND INTERACTION WITH SRC.
RX   PubMed=9344858; DOI=10.1006/bbrc.1997.7493;
RA   Cirri P., Chiarugi P., Marra F., Raugei G., Camici G., Manao G.,
RA   Ramponi G.;
RT   "c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells.";
RL   Biochem. Biophys. Res. Commun. 239:493-497(1997).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=11294897; DOI=10.1091/mbc.12.4.931;
RA   Hart K.C., Robertson S.C., Donoghue D.J.;
RT   "Identification of tyrosine residues in constitutively activated fibroblast
RT   growth factor receptor 3 involved in mitogenesis, Stat activation, and
RT   phosphatidylinositol 3-kinase activation.";
RL   Mol. Biol. Cell 12:931-942(2001).
RN   [4]
RP   PHOSPHORYLATION, AND DEPHOSPHORYLATION BY PTPN2.
RX   PubMed=12138178; DOI=10.1128/mcb.22.16.5662-5668.2002;
RA   ten Hoeve J., de Jesus Ibarra-Sanchez M., Fu Y., Zhu W., Tremblay M.,
RA   David M., Shuai K.;
RT   "Identification of a nuclear Stat1 protein tyrosine phosphatase.";
RL   Mol. Cell. Biol. 22:5662-5668(2002).
RN   [5]
RP   FUNCTION, PHOSPHORYLATION AT SER-727, AND MUTAGENESIS OF SER-727.
RX   PubMed=11972023; DOI=10.1073/pnas.052159099;
RA   Nair J.S., DaFonseca C.J., Tjernberg A., Sun W., Darnell J.E. Jr.,
RA   Chait B.T., Zhang J.J.;
RT   "Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in
RT   response to IFN-gamma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5971-5976(2002).
RN   [6]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [7]
RP   IDENTIFICATION IN THE ISGF3 COMPLEX, PHOSPHORYLATION AT SER-708 AND
RP   SER-744, AND MUTAGENESIS OF SER-708 AND 744-SER--SER-747.
RX   PubMed=17332413; DOI=10.1126/science.1136567;
RA   Tenoever B.R., Ng S.L., Chua M.A., McWhirter S.M., Garcia-Sastre A.,
RA   Maniatis T.;
RT   "Multiple functions of the IKK-related kinase IKKepsilon in interferon-
RT   mediated antiviral immunity.";
RL   Science 315:1274-1278(2007).
RN   [8]
RP   FUNCTION, AND PHOSPHORYLATION AT TYR-701 IN RESPONSE TO CONSTITUTIVELY
RP   ACTIVATED FGFR3.
RX   PubMed=19088846; DOI=10.1371/journal.pone.0003961;
RA   Krejci P., Salazar L., Kashiwada T.A., Chlebova K., Salasova A.,
RA   Thompson L.M., Bryja V., Kozubik A., Wilcox W.R.;
RT   "Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal
RT   dysplasia undermines dominant role of STAT1 in FGFR3 signaling in
RT   cartilage.";
RL   PLoS ONE 3:E3961-E3961(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10]
RP   PHOSPHORYLATION IN RESPONSE TO KIT SIGNALING.
RX   PubMed=21135090; DOI=10.1074/jbc.m110.182642;
RA   Chaix A., Lopez S., Voisset E., Gros L., Dubreuil P., De Sepulveda P.;
RT   "Mechanisms of STAT protein activation by oncogenic KIT mutants in
RT   neoplastic mast cells.";
RL   J. Biol. Chem. 286:5956-5966(2011).
RN   [11]
RP   FUNCTION, AND PHOSPHORYLATION AT TYR-701; SER-708 AND SER-727.
RX   PubMed=22065572; DOI=10.1074/jbc.m111.285205;
RA   Perwitasari O., Cho H., Diamond M.S., Gale M. Jr.;
RT   "Inhibitor of kappaB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2
RT   proteins define novel innate immune effector pathway against West Nile
RT   virus infection.";
RL   J. Biol. Chem. 286:44412-44423(2011).
RN   [12]
RP   INTERACTION WITH OTOP1.
RX   PubMed=24379350; DOI=10.2337/db13-1139;
RA   Wang G.X., Cho K.W., Uhm M., Hu C.R., Li S., Cozacov Z., Xu A.E.,
RA   Cheng J.X., Saltiel A.R., Lumeng C.N., Lin J.D.;
RT   "Otopetrin 1 protects mice from obesity-associated metabolic dysfunction
RT   through attenuating adipose tissue inflammation.";
RL   Diabetes 63:1340-1352(2014).
RN   [13]
RP   FUNCTION.
RX   PubMed=37327784; DOI=10.1016/j.cell.2023.05.027;
RA   He K., Wan T., Wang D., Hu J., Zhou T., Tao W., Wei Z., Lu Q., Zhou R.,
RA   Tian Z., Flavell R.A., Zhu S.;
RT   "Gasdermin D licenses MHCII induction to maintain food tolerance in small
RT   intestine.";
RL   Cell 0:0-0(2023).
RN   [14]
RP   PHOSPHORYLATION AT TYR-701; SER-727 AND THR-748, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF THR-748.
RX   PubMed=38621137; DOI=10.1073/pnas.2402226121;
RA   Metwally H., Elbrashy M.M., Ozawa T., Okuyama K., White J.T., Tulyeu J.,
RA   Soendergaard J.N., Wing J.B., Muratsu A., Matsumoto H., Ikawa M., Kishi H.,
RA   Taniuchi I., Kishimoto T.;
RT   "Threonine phosphorylation of STAT1 restricts interferon signaling and
RT   promotes innate inflammatory responses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 121:e2402226121-e2402226121(2024).
CC   -!- FUNCTION: Signal transducer and transcription activator that mediates
CC       cellular responses to interferons (IFNs), cytokine KITLG/SCF and other
CC       cytokines and other growth factors (PubMed:11294897, PubMed:11972023,
CC       PubMed:19088846, PubMed:22065572, PubMed:9344858). Following type I IFN
CC       (IFN-alpha and IFN-beta) binding to cell surface receptors, signaling
CC       via protein kinases leads to activation of Jak kinases (TYK2 and JAK1)
CC       and to tyrosine phosphorylation of STAT1 and STAT2 (By similarity). The
CC       phosphorylated STATs dimerize and associate with ISGF3G/IRF-9 to form a
CC       complex termed ISGF3 transcription factor, that enters the nucleus (By
CC       similarity). ISGF3 binds to the IFN stimulated response element (ISRE)
CC       to activate the transcription of IFN-stimulated genes (ISG), which
CC       drive the cell in an antiviral state (PubMed:22065572). In response to
CC       type II IFN (IFN-gamma), STAT1 is tyrosine- and serine-phosphorylated
CC       (PubMed:11972023). It then forms a homodimer termed IFN-gamma-activated
CC       factor (GAF), migrates into the nucleus and binds to the IFN gamma
CC       activated sequence (GAS) to drive the expression of the target genes,
CC       inducing a cellular antiviral state (By similarity). Becomes activated
CC       in response to KITLG/SCF and KIT signaling (By similarity). May mediate
CC       cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4
CC       (PubMed:19088846). Following bacterial lipopolysaccharide (LPS)-induced
CC       TLR4 endocytosis, phosphorylated at Thr-748 by IKBKB which promotes
CC       binding of STAT1 to the 5'-TTTGAGGC-3' sequence in the ARID5A promoter,
CC       resulting in transcriptional activation of ARID5A and subsequent
CC       ARID5A-mediated stabilization of IL6 (By similarity). Phosphorylation
CC       at Thr-748 also promotes binding of STAT1 to the 5'-TTTGAGTC-3'
CC       sequence in the IL12B promoter and activation of IL12B transcription
CC       (By similarity). Involved in food tolerance in small intestine:
CC       associates with the Gasdermin-D, p13 cleavage product (13 kDa GSDMD)
CC       and promotes transcription of CIITA, inducing type 1 regulatory T (Tr1)
CC       cells in upper small intestine (PubMed:37327784).
CC       {ECO:0000250|UniProtKB:P42224, ECO:0000269|PubMed:11294897,
CC       ECO:0000269|PubMed:11972023, ECO:0000269|PubMed:19088846,
CC       ECO:0000269|PubMed:22065572, ECO:0000269|PubMed:37327784,
CC       ECO:0000269|PubMed:9344858}.
CC   -!- SUBUNIT: Homodimerizes upon IFN-gamma induced phosphorylation (By
CC       similarity). Heterodimer with STAT2 upon IFN-alpha/beta induced
CC       phosphorylation (By similarity). The heterodimer STAT1:STAT2 forms the
CC       interferon-stimulated gene factor 3 complex (ISGF3) with IRF9
CC       (PubMed:17332413). Interacts (phosphorylated at Ser-727) with PIAS1;
CC       the interaction results in release of STAT1 from its target gene (By
CC       similarity). Interacts with IFNAR1 (By similarity). Interacts with
CC       IFNAR2 (By similarity). Found in a complex with NMI and CREBBP/CBP (By
CC       similarity). Interacts with NMI which is required for CREBBP/CBP
CC       recruitment to the complex (By similarity). Interacts with PTK2/FAK1
CC       (By similarity). Interacts with SRC (PubMed:9344858). Interacts with
CC       ERBB4 (phosphorylated) (By similarity). Interacts with PARP9 and DTX3L
CC       independently of IFN-beta or IFN-gamma-mediated STAT1 'Tyr-701'
CC       phosphorylation (By similarity). Interacts with histone
CC       acetyltransferase EP300/p300 in response to INF-gamma stimulation (By
CC       similarity). Independently of its phosphorylation status, interacts
CC       with OTOP1 (PubMed:24379350). Interacts with IFNGR1 (By similarity).
CC       Interacts with STAT4 (By similarity). {ECO:0000250|UniProtKB:P42224,
CC       ECO:0000269|PubMed:17332413, ECO:0000269|PubMed:24379350,
CC       ECO:0000269|PubMed:9344858}.
CC   -!- INTERACTION:
CC       P42225; P29351: Ptpn6; NbExp=2; IntAct=EBI-647118, EBI-2620699;
CC       P42225; P42228: Stat4; NbExp=2; IntAct=EBI-647118, EBI-6253572;
CC       P42225; Q61069: Usf1; NbExp=2; IntAct=EBI-647118, EBI-2325635;
CC       P42225; Q64705: Usf2; NbExp=3; IntAct=EBI-647118, EBI-647583;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11294897}. Nucleus
CC       {ECO:0000269|PubMed:11294897}. Note=Translocated into the nucleus upon
CC       tyrosine phosphorylation and dimerization, in response to IFN-gamma and
CC       signaling by activated FGFR1, FGFR2, FGFR3 or FGFR4. Monomethylation at
CC       Lys-525 is required for phosphorylation at Tyr-701 and translocation
CC       into the nucleus. Translocates into the nucleus in response to
CC       interferon-beta stimulation. {ECO:0000250|UniProtKB:P42224}.
CC   -!- INDUCTION: By IFN and EGF.
CC   -!- PTM: Phosphorylated on tyrosine and serine residues in response to a
CC       variety of cytokines/growth hormones including IFN-alpha, IFN-gamma,
CC       PDGF and EGF (PubMed:11294897, PubMed:22065572, PubMed:9344858).
CC       Activated KIT promotes phosphorylation on tyrosine residues and
CC       subsequent translocation to the nucleus (PubMed:21135090). Upon EGF
CC       stimulation, phosphorylation on Tyr-701 (lacking in beta form) by JAK1,
CC       JAK2 or TYK2 promotes dimerization and subsequent translocation to the
CC       nucleus (PubMed:22065572). Growth hormone (GH) activates STAT1
CC       signaling only via JAK2 (By similarity). Tyrosine phosphorylated in
CC       response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4
CC       (PubMed:19088846). Phosphorylation on Ser-727 by several kinases
CC       including MAPK14, ERK1/2 and CAMK2/CAMKII in response to IFN-gamma
CC       stimulation, is required for maximal transcriptional activity
CC       (PubMed:11972023, PubMed:22065572). Phosphorylated on Ser-727 by
CC       CAMK2/CAMKII in response to IFN-gamma stimulation and calcium
CC       mobilization, promoting activity (PubMed:11972023). Phosphorylated by
CC       CAMK2/CAMKII in response to IFN-beta stimulation and calcium
CC       mobilization in epithelial cells, promoting activity (By similarity).
CC       Phosphorylation on Ser-727 promotes sumoylation though increasing
CC       interaction with PIAS (By similarity). Phosphorylation on Ser-727 by
CC       PRKCD induces apoptosis in response to DNA-damaging agents (By
CC       similarity). Phosphorylated on tyrosine residues when PTK2/FAK1 is
CC       activated; most likely this is catalyzed by a SRC family kinase
CC       (PubMed:12138178). Dephosphorylation on tyrosine residues by PTPN2
CC       negatively regulates interferon-mediated signaling (By similarity).
CC       Upon viral infection or IFN induction, phosphorylation on Ser-708
CC       occurs much later than phosphorylation on Tyr-701 and is required for
CC       the binding of ISGF3 on the ISREs of a subset of IFN-stimulated genes
CC       IKBKE-dependent (PubMed:17332413). Phosphorylation at Tyr-701 and Ser-
CC       708 are mutually exclusive, phosphorylation at Ser-708 requires
CC       previous dephosphorylation of Tyr-701 (PubMed:17332413).
CC       Phosphorylation at Thr-748 by IKBKB/IKKB promotes transcriptional
CC       activation of ARID5A and IL12B by STAT1 (By similarity).
CC       Phosphorylation at Thr-748 restricts interferon signaling and anti-
CC       inflammatory responses and promotes innate inflammatory responses
CC       (PubMed:38621137). {ECO:0000250|UniProtKB:P42224,
CC       ECO:0000269|PubMed:11294897, ECO:0000269|PubMed:11972023,
CC       ECO:0000269|PubMed:12138178, ECO:0000269|PubMed:17332413,
CC       ECO:0000269|PubMed:19088846, ECO:0000269|PubMed:21135090,
CC       ECO:0000269|PubMed:22065572, ECO:0000269|PubMed:38621137,
CC       ECO:0000269|PubMed:9344858}.
CC   -!- PTM: Sumoylated with SUMO1, SUMO2 and SUMO3. Sumoylation is enhanced by
CC       IFN-gamma-induced phosphorylation on Ser-727, and by interaction with
CC       PIAS proteins. Enhances the transactivation activity.
CC       {ECO:0000250|UniProtKB:P42224}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: Mono-ADP-ribosylated at Glu-657 and Glu-705 by PARP14; ADP-
CC       ribosylation prevents phosphorylation at Tyr-701. However, the role of
CC       ADP-ribosylation in the prevention of phosphorylation has been called
CC       into question and the lack of phosphorylation may be due to sumoylation
CC       of Lys-703. {ECO:0000250|UniProtKB:P42224}.
CC   -!- PTM: Monomethylated at Lys-525 by SETD2; monomethylation is necessary
CC       for phosphorylation at Tyr-701, translocation into the nucleus and
CC       activation of the antiviral defense. {ECO:0000250|UniProtKB:P42224}.
CC   -!- PTM: Deubiquitinated by USP13; leading to STAT1 stabilization and
CC       positive regulation of type I and type II IFN signalings.
CC       {ECO:0000250|UniProtKB:P42224}.
CC   -!- DISRUPTION PHENOTYPE: Resistance to bacterial lipopolysaccharide (LPS)-
CC       induced lethality. {ECO:0000269|PubMed:38621137}.
CC   -!- SIMILARITY: Belongs to the transcription factor STAT family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Has been shown to be mono-ADP-ribosylated at Glu-657 and Glu-
CC       705 by PARP14 which prevents phosphorylation at Tyr-701 (By
CC       similarity). However, the role of ADP-ribosylation in the prevention of
CC       phosphorylation has been called into question (By similarity). It has
CC       been suggested that the lack of phosphorylation may be due to
CC       sumoylation of Lys-703 (By similarity). {ECO:0000250|UniProtKB:P42224}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U06924; AAA19454.1; -; mRNA.
DR   CCDS; CCDS56628.1; -.
DR   AlphaFoldDB; P42225; -.
DR   SMR; P42225; -.
DR   DIP; DIP-38739N; -.
DR   FunCoup; P42225; 1803.
DR   IntAct; P42225; 22.
DR   MINT; P42225; -.
DR   STRING; 10090.ENSMUSP00000141132; -.
DR   BindingDB; P42225; -.
DR   ChEMBL; CHEMBL1667670; -.
DR   GlyGen; P42225; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P42225; -.
DR   PhosphoSitePlus; P42225; -.
DR   SwissPalm; P42225; -.
DR   jPOST; P42225; -.
DR   PaxDb; 10090-ENSMUSP00000066743; -.
DR   PeptideAtlas; P42225; -.
DR   ProteomicsDB; 257088; -.
DR   Pumba; P42225; -.
DR   AGR; MGI:103063; -.
DR   MGI; MGI:103063; Stat1.
DR   eggNOG; KOG3667; Eukaryota.
DR   InParanoid; P42225; -.
DR   PhylomeDB; P42225; -.
DR   Reactome; R-MMU-1059683; Interleukin-6 signaling.
DR   Reactome; R-MMU-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-MMU-1433557; Signaling by SCF-KIT.
DR   Reactome; R-MMU-186763; Downstream signal transduction.
DR   Reactome; R-MMU-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-MMU-877300; Interferon gamma signaling.
DR   Reactome; R-MMU-877312; Regulation of IFNG signaling.
DR   Reactome; R-MMU-8854691; Interleukin-20 family signaling.
DR   Reactome; R-MMU-8984722; Interleukin-35 Signalling.
DR   Reactome; R-MMU-8985947; Interleukin-9 signaling.
DR   Reactome; R-MMU-9020956; Interleukin-27 signaling.
DR   Reactome; R-MMU-9020958; Interleukin-21 signaling.
DR   Reactome; R-MMU-909733; Interferon alpha/beta signaling.
DR   Reactome; R-MMU-912694; Regulation of IFNA/IFNB signaling.
DR   Reactome; R-MMU-9833482; PKR-mediated signaling.
DR   Reactome; R-MMU-9860927; Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells.
DR   SABIO-RK; P42225; -.
DR   ChiTaRS; Stat1; mouse.
DR   PRO; PR:P42225; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; P42225; protein.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0008015; P:blood circulation; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; IGI:MGI.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; IDA:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISO:MGI.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IMP:MGI.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0051607; P:defense response to virus; IMP:ARUK-UCL.
DR   GO; GO:0006351; P:DNA-templated transcription; IMP:MGI.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:MGI.
DR   GO; GO:0072162; P:metanephric mesenchymal cell differentiation; ISS:UniProtKB.
DR   GO; GO:0072136; P:metanephric mesenchymal cell proliferation involved in metanephros development; ISS:UniProtKB.
DR   GO; GO:0034240; P:negative regulation of macrophage fusion; IMP:MGI.
DR   GO; GO:0003340; P:negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB.
DR   GO; GO:0072308; P:negative regulation of metanephric nephron tubule epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0032727; P:positive regulation of interferon-alpha production; ISS:UniProtKB.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISS:UniProtKB.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0061326; P:renal tubule development; ISS:UniProtKB.
DR   GO; GO:0009617; P:response to bacterium; IDA:MGI.
DR   GO; GO:0051591; P:response to cAMP; ISS:UniProtKB.
DR   GO; GO:0034097; P:response to cytokine; ISS:UniProtKB.
DR   GO; GO:0043330; P:response to exogenous dsRNA; IDA:MGI.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IDA:MGI.
DR   GO; GO:0043434; P:response to peptide hormone; ISS:UniProtKB.
DR   GO; GO:0034340; P:response to type I interferon; IDA:UniProtKB.
DR   GO; GO:0034341; P:response to type II interferon; IDA:UniProtKB.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060333; P:type II interferon-mediated signaling pathway; IMP:UniProtKB.
DR   CDD; cd10372; SH2_STAT1; 1.
DR   CDD; cd16851; STAT1_CCD; 1.
DR   CDD; cd16845; STAT1_DBD; 1.
DR   FunFam; 1.10.238.10:FF:000012; Signal transducer and activator of transcription; 1.
DR   FunFam; 1.10.532.10:FF:000001; Signal transducer and activator of transcription; 1.
DR   FunFam; 1.20.1050.20:FF:000001; Signal transducer and activator of transcription; 1.
DR   FunFam; 2.60.40.630:FF:000001; Signal transducer and activator of transcription; 1.
DR   FunFam; 3.30.505.10:FF:000003; Signal transducer and activator of transcription; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 1.
DR   Gene3D; 6.10.250.3310; signal transducer and activator of transcription 1; 1.
DR   Gene3D; 1.20.1050.20; STAT transcription factor, all-alpha domain; 1.
DR   Gene3D; 2.60.40.630; STAT transcription factor, DNA-binding domain; 1.
DR   Gene3D; 1.10.532.10; STAT transcription factor, N-terminal domain; 1.
DR   InterPro; IPR008967; p53-like_TF_DNA-bd_sf.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR001217; STAT.
DR   InterPro; IPR038295; STAT1_C_sf.
DR   InterPro; IPR035859; STAT1_SH2.
DR   InterPro; IPR022752; STAT1_TAZ2-bd_C.
DR   InterPro; IPR048988; STAT_linker.
DR   InterPro; IPR036535; STAT_N_sf.
DR   InterPro; IPR013800; STAT_TF_alpha.
DR   InterPro; IPR015988; STAT_TF_coiled-coil.
DR   InterPro; IPR013801; STAT_TF_DNA-bd.
DR   InterPro; IPR012345; STAT_TF_DNA-bd_N.
DR   InterPro; IPR013799; STAT_TF_prot_interaction.
DR   PANTHER; PTHR11801; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; 1.
DR   Pfam; PF00017; SH2; 1.
DR   Pfam; PF12162; STAT1_TAZ2bind; 1.
DR   Pfam; PF01017; STAT_alpha; 1.
DR   Pfam; PF02864; STAT_bind; 1.
DR   Pfam; PF02865; STAT_int; 1.
DR   Pfam; PF21354; STAT_linker; 1.
DR   SMART; SM00964; STAT_int; 1.
DR   SUPFAM; SSF49417; p53-like transcription factors; 1.
DR   SUPFAM; SSF55550; SH2 domain; 1.
DR   SUPFAM; SSF47655; STAT; 1.
DR   SUPFAM; SSF48092; Transcription factor STAT-4 N-domain; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; ADP-ribosylation; Coiled coil; Cytoplasm;
KW   DNA-binding; Isopeptide bond; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; SH2 domain; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   CHAIN           2..749
FT                   /note="Signal transducer and activator of transcription 1"
FT                   /id="PRO_0000182411"
FT   DOMAIN          573..670
FT                   /note="SH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191"
FT   COILED          136..317
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   SITE            724
FT                   /note="Required for recruitment of EP300/p300"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         114
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         175
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         296
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         366
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         525
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         637
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         657
FT                   /note="ADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         665
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         701
FT                   /note="Phosphotyrosine; by JAK1, JAK2 or TYK2"
FT                   /evidence="ECO:0000269|PubMed:19088846,
FT                   ECO:0000269|PubMed:22065572, ECO:0000269|PubMed:38621137"
FT   MOD_RES         705
FT                   /note="ADP-ribosyl glutamic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MOD_RES         708
FT                   /note="Phosphoserine; by IKKE"
FT                   /evidence="ECO:0000269|PubMed:17332413,
FT                   ECO:0000269|PubMed:22065572"
FT   MOD_RES         727
FT                   /note="Phosphoserine; by CaMK2 and MAPK14"
FT                   /evidence="ECO:0000269|PubMed:11972023,
FT                   ECO:0000269|PubMed:22065572, ECO:0000269|PubMed:38621137"
FT   MOD_RES         744
FT                   /note="Phosphoserine; by IKKE"
FT                   /evidence="ECO:0000305|PubMed:17332413"
FT   MOD_RES         748
FT                   /note="Phosphothreonine; by IKKB"
FT                   /evidence="ECO:0000269|PubMed:38621137"
FT   CROSSLNK        703
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   CROSSLNK        703
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P42224"
FT   MUTAGEN         708
FT                   /note="Missing: Strongly decreases ISGF3 binding to the
FT                   ISRE of IKBKE-dependent genes but noo effect on ISGF3
FT                   binding to the ISRE of IKBKE-independent genes."
FT                   /evidence="ECO:0000269|PubMed:17332413"
FT   MUTAGEN         727
FT                   /note="S->A: Abolished phosphorylation by CaMK2 in response
FT                   to IFN-gamma, leading to decreased transcriptional
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:11972023"
FT   MUTAGEN         744..747
FT                   /note="SMMS->MM: No effect on ISGF3 binding to ISREs."
FT                   /evidence="ECO:0000269|PubMed:17332413"
FT   MUTAGEN         748
FT                   /note="T->A: Abolishes IKKB-mediated phosphorylation at
FT                   this position. Confers resistance to bacterial
FT                   lipopolysaccharide (LPS)-induced lethality without
FT                   affecting Stat1 protein expression or interferon signaling.
FT                   Enhances interferon signaling following LPS stimulation of
FT                   bone marrow-derived macrophages."
FT                   /evidence="ECO:0000269|PubMed:38621137"
SQ   SEQUENCE   749 AA;  87197 MW;  249D919952BE65F1 CRC64;
     MSQWFELQQL DSKFLEQVHQ LYDDSFPMEI RQYLAQWLEK QDWEHAAYDV SFATIRFHDL
     LSQLDDQYSR FSLENNFLLQ HNIRKSKRNL QDNFQEDPVQ MSMIIYNCLK EERKILENAQ
     RFNQAQEGNI QNTVMLDKQK ELDSKVRNVK DQVMCIEQEI KTLEELQDEY DFKCKTSQNR
     EGEANGVAKS DQKQEQLLLH KMFLMLDNKR KEIIHKIREL LNSIELTQNT LINDELVEWK
     RRQQSACIGG PPNACLDQLQ TWFTIVAETL QQIRQQLKKL EELEQKFTYE PDPITKNKQV
     LSDRTFLLFQ QLIQSSFVVE RQPCMPTHPQ RPLVLKTGVQ FTVKSRLLVK LQESNLLTKV
     KCHFDKDVNE KNTVKGFRKF NILGTHTKVM NMEESTNGSL AAELRHLQLK EQKNAGNRTN
     EGPLIVTEEL HSLSFETQLC QPGLVIDLET TSLPVVVISN VSQLPSGWAS ILWYNMLVTE
     PRNLSFFLNP PCAWWSQLSE VLSWQFSSVT KRGLNADQLS MLGEKLLGPN AGPDGLIPWT
     RFCKENINDK NFSFWPWIDT ILELIKNDLL CLWNDGCIMG FISKERERAL LKDQQPGTFL
     LRFSESSREG AITFTWVERS QNGGEPDFHA VEPYTKKELS AVTFPDIIRN YKVMAAENIP
     ENPLKYLYPN IDKDHAFGKY YSRPKEAPEP MELDDPKRTG YIKTELISVS EVHPSRLQTT
     DNLLPMSPEE FDEMSRIVGP EFDSMMSTV
//
